The Value of a Panel of Autoantibodies for Predicting the Activity of Lupus Nephritis at Time of Renal Biopsy

Table 5

Predictors of complete renal remissions among the clinical and the immunological tests at renal biopsy.

	Complete remission; 39 patients	No complete remission; 65 patients
Months of therapy	6.0 (5.2–7.4)	5.2 (3.5–6.8)	0.02
Serum creatinine mg/dL	0.83 (0.64–0.95)	0.85 (0.7–1.26)	0.15
Proteinuria g/day	1.96 (12–2.76)	3.45 (2.1–5)	0.0009
Hemoglobin g/dL	12.0 (11.0–12.9)	11.6 (10–12.7)	0.12
Erythrocyte sedimentation rate	33 (17.5–61.2)	39 (16–73)	0.7
C reactive protein mg/dL	0.3 (0.09–1.22)	0.3 (0.14–0.67)	0.6
C3 mg/dL	66 (48–82.2)	70 (48–88)	0.5
C4 mg/dL	9 (5.2–115.7)	10 (5–14)	0.7
Anti DNA antibodies U/mL	147 (83.5–380)	132 (43–400)	0.5
Anti C1q antibodies AU	120 (35–320)	128 (42.5–320)	0.5
Anti-nucleosome antibodies U	88 (57–111)	92.5 (33.2–115.7)	0.8
Anti-DNA >55 U/mL or anti-C1q >50 AU antibodies	34 (87%)	58 (89,2%)	1
Anti-ribosome antibodies	2 (2–5.5)	2 (2–5.7)	0.1

The data are reported as Median and interquartile ranges.